Home / Contract Awards / Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

LeidosLogoLeidos (NYSE: LDOS) has been awarded a potential five-year, $23.7 million contract to support the U.S. Agency for International Development‘s efforts to research and develop a vaccine against malaria.

The company said Monday it will provide scientific and management services for USAID’s Malaria Vaccine Development Program under the cost-plus-fixed-fee contract.

Jerry Hogge, Leidos health deputy group president, said the company brings decades of life sciences technology and experience to the USAID program.

Leidos said the work to occur in Frederick, Maryland, could also evaluate malaria vaccine candidates during preclinical studies and clinical and field trials.

The company’s life sciences team supports medical product R&D efforts at the National Institutes of Health and the departments of Defense and Homeland Security.

Check Also

IntelliDyne Founder Robert Grey Returns to CEO Post

Robert Grey, founder of IntelliDyne, has been appointed to serve again as CEO of the Falls Church, Va.-based information technology services provider.

Charles Romine, Director of NIST IT Lab, to Give Keynote Address at Potomac Officers Club’s AI Summit 2020 on Feb. 13th

Charles Romine, director of the Information Technology Laboratory (ITL) at the National Institute of Standards and Technology (NIST), will serve as a keynote speaker during Potomac Officers Club’s 2nd Annual Artificial Intelligence Summit 2020 on Thursday, Feb. 13th.